MLA 0.00% 8.5¢ medical australia limited

orphan annie, analytica and the autostart, page-18

  1. 183 Posts.
    jessie , please point out the holes in my post ? retorting with generalist comments such as yours doesn't prove a point. please correct any untruths in my post ?

    your comments are untrue or at best deceiving as you are now trying to twist your words. you said "ALT needs MLA to be succesful" period. you never said right now or qualified in what capacity. you implied that without MLA, ALT would fail.

    i left out the UK market in my first post correct, but corrected the error. do you have any idea as to the size of the UK market ? I think not.

    The problem I have, is that you are implying MLA is ALT's only chance, and writing as though MLA are their worldwide distributor. Again, distorting the facts to prove your point. It is fact that MLA only have exclusivity over Australian, New Zealand and UK. MLA can have the view to expand into other markets all they like, and indeed they are allowed to report this to the market, doesn't mean squat.

    ALT have the final decision on who they use for the rest of the world which is what you fail to accept. Until it is announced to the market and a signed deal, MLA do not have exclusivity outside AUS, NZ and UK. You are riding on the coatails of the $3billion market figure, which is not MLA's exclusively.

    MLA at this stage has a slice of an $88million pie

    ALT could potentially have a slice of a $3billion pie

    This is why ALT will outperform MLA, purely on speculation and the size of the potential market. If MLA can secure ALT the domestic market, the international market is the next logical step, which is what punters are betting on.
 
watchlist Created with Sketch. Add MLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.